ArticleThe Journal of physiology2026
Piperine disrupts the OFF state of the resting thick filament of rat skeletal muscle, enhancing dynamic contractility in a fibre-type-dependent manner.
Article in The Journal of physiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
The myosin-containing thick filament has been shown to alter its resting structure in response to multiple diseases and therapeutics. Changes in thick filament resting structure are caused by myosin heads transitioning between ordered and disordered OFF conformational states. Functionally, this modulation of thick filament structure is a key regulatory step in muscle contraction and a promising therapeutic target. The availability of disordered myosin heads governs dynamic contractility, which is critical to physical function and well-being. At present, there is a lack of compounds favouring this disordered state in resting skeletal muscle. Piperine is a molecule known to bind to myosin and increase submaximal isometric contractility in fast and slow skeletal muscle. However, the effects on dynamic contractility and the underlying mechanism responsible for the observed effects in skeletal muscles remain unclear. Here, we used fibre small-angle X-ray diffraction and intact-muscle ex vivo contractility experiments to determine the effects of piperine on resting myosin structure and dynamic contractility in fast and slow rat muscles. X-ray diffraction data suggest that piperine promotes a priming of myosin in resting skeletal muscle from an ordered OFF state to a disordered OFF state, increasing the availability of myosin heads for force generation. Functionally, piperine substantially enhanced submaximal dynamic contractility in both muscle types, while only leading to improvements in slow muscle during maximal electrical stimulation. These findings establish piperine as a tool for priming the thick filament in skeletal muscle, highlighting muscle-type-specific effects of thick-filament modulation on the recruitment of the contractile reserve capacity. KEY POINTS: Piperine is a compound known to bind to skeletal muscle myosin and enhance isometric contractility in fast and slow muscles, but its effect on dynamic muscle function and the underlying molecular mechanism remain unknown. We show that piperine disrupts the ordered OFF state of the myosin-containing thick filament in resting fast and slow skeletal muscle, which likely explains the effect of piperine on contractile function. Piperine substantially increases contractile power of both fast and slow skeletal muscles at low-frequency stimulation; however, it only enhances power in slow skeletal muscle at high-frequency stimulation. Our data reveal potentiation of dynamic contractility with fibre-type-dependent magnitudes in response to piperine-induced priming of the resting thick filament, which is a phenomenon requiring further investigation. Dynamic contractility drives locomotion in vivo; therefore, thick-filament priming may ultimately be exploited in the treatment of diseases characterised by skeletal muscle weakness.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.